FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Pioglitazone Hydrochloride and Metformin Hydrochloride Tablets
Status: Discontinuation
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Mylan Pharmaceuticals Inc. (New 06/19/2018)

Company Contact Information:
800-RXMYLAN (1-800-496-9526)

Presentation Posting Date Related Information
15 mg/500 mg, 60 count bottle (NDC 0378-1550-91) 06/19/2018 The discontinuation of this product is a business decision.
15 mg/850 mg, 60 count bottle (NDC 0378-1575-91) 06/19/2018 The discontinuation of this product is a business decision.

Teva Pharmaceuticals (New 07/03/2018)

Company Contact Information:
800-545-8800

Presentation Posting Date Related Information
500mg/15mg tablets (NDCs 0093-7677-06 and 0093-7677-86) 07/03/2018 This product discontinuation is a business related decision.
850m/15mg tablets (NDCs 0093-7678-06 and 0093-7678-86) 07/03/2018 This product discontinuation is a business related decision.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English